MME961

home > TISSUE ARRAYS > Melanoma > MME961

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Adrenal Gland
- Appendix
- Bladder
- Bone_Cartilage
- Bone_Marrow
- Breast
- Colon
- Dog
- Endometrium
- Esophagogastric junction
- Esophagus
- Fallopian tube
- Fetus
- Gall bladder and bile duct
- Head_Neck
- Heart
- Intestine
- Kidney
- Liver
- Lung
- Melanoma
- Monkey (Cynomolgus) (Normal)-CyFPT
- Monkey (Rhesus) (Normal)-RsFPT
- Mouse
- Multiple organ
- Oral_Cavity
- Ovary
- Pancreas
- Penis
- Rat
- Rectum
- Skin
- Soft_Tissue
- Spleen
- Stomach
- Testis
- Thymus
- Uterus
- Vulva
Types/Disease
Cores
Cases

Cores:

96

CASES:

96

Core Diameter(mm):

1

Thickness(µm):

5

Row number:

10

Column number:

10

Tissue Array Type:

FFPE

Species:

Human

MME961

$255.00

Description: Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 96 cases/96 cores

Details: Malignant melanoma, metastatic malignant melanoma and nevus tissue microarray, containing 74 cases of malignant melanoma, 14 metastatic malignant melanoma, 8 nevus tissue, single core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

96 Cores 96 Cases Melanoma Metastasis special price single core per case

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

Metastasis(*)
-(*)
Benign(*)
Malignant()
Malignant(*)
Malignant(I)
Malignant(IIA)
Malignant(IIB)
Malignant(IIC)
Malignant(II)
Malignant(IIIB)
Malignant(III)
Malignant(IV)

TISSUE ARRAYS
MME961

	1	2	3	4	5	6	7	8	9	10
A	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
B	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
C	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
D	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
E	Ski	Ski	Ski	Ski	Rec	Rec	Rec	Rec	Rec	Rec
F	Rec	Rec	Rec	Rec	Rec	Nos	Nos	Nos	Nos	Nos
G	Nos	Eye	Eye	Vul	Vul	Eso	Eso	Sto	Sma	Ora
H	Ure	Med	Scr	Scr	Lym	Lym	Lym	Lym	Lym	Lym
I	Lym	Lym	Lym	Lym	Lym	Lym	Lym	Lym	-	-
J	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski

MME961

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type	HMB45	S-100
A1	1	62	F	Skin	Malignant melanoma of right thumb	-	T4aN0M0	II	Malignant	++,70%,cytoplasm	++,70%,Cytoplasmic nucleus
A2	2	56	M	Skin	Malignant melanoma of abdomen	-	T4aN0M0	II	Malignant	+++,90%,cytoplasm	++,60%,Cytoplasmic nucleus
A3	3	61	M	Skin	Malignant melanoma with necrosis of right plantar	-	T4N0M0	II	Malignant	-	++,50%,Cytoplasmic nucleus
A4	4	45	F	Skin	Malignant melanoma of right chest wall	-	T3bN0M0	IIB	Malignant	-	-
A5	5	52	M	Skin	Malignant melanoma of anal canal (bleeding)	-	T3N0M0	IIA	Malignant	-	-
A6	6	47	F	Skin	Malignant melanoma of left upper arm	-	T4aN0M0	IIB	Malignant	+,40%,cytoplasm	+++,80%,Cytoplasmic nucleus
A7	7	53	M	Skin	Malignant melanoma of right plantar (sparse)	-	T4N0M0	II	Malignant	-	-
A8	8	62	F	Skin	Malignant melanoma of right foot	-	T4N0M0	II	Malignant	+++,90%,cytoplasm	+++,90%,Cytoplasmic nucleus
A9	9	65	M	Skin	Malignant melanoma of scalp	-	T3aN0M0	IIA	Malignant	+,60%,cytoplasm	+,50%,Cytoplasmic nucleus
A10	10	54	F	Skin	Malignant melanoma of right foot	-	T4aN0M0	II	Malignant	+,90%,cytoplasm	++,90%,Cytoplasmic nucleus
B1	11	55	M	Skin	Malignant melanoma of right forearm	-	T4N0M0	II	Malignant	++,90%,cytoplasm	++,90%,Cytoplasmic nucleus
B2	12	65	M	Skin	Malignant melanoma of right plantar	-	T2bN0M0	IIA	Malignant	++,70%,cytoplasm	++,80%,Cytoplasmic nucleus
B3	13	31	M	Skin	Malignant melanoma of scalp	-	T4aN0M0	II	Malignant	-	++,90%,Cytoplasmic nucleus
B4	14	42	M	Skin	Malignant melanoma with sparse necrosis of left heel	-	T3aN0M0	IIA	Malignant	+++,90%,cytoplasm	+,15%,Cytoplasmic nucleus
B5	15	49	M	Skin	Malignant melanoma of left foot	-	T4N2M0	III	Malignant	+,60%,cytoplasm	++,70%,Cytoplasmic nucleus
B6	16	60	M	Skin	Malignant melanoma of right buttock	-	T4aN0M0	IIB	Malignant	-	++,40%,Cytoplasmic nucleus
B7	17	40	M	Skin	Malignant melanoma of right upper arm	-	T4aN0M0	IIB	Malignant	++,50%,cytoplasm	+++,70%,Cytoplasmic nucleus
B8	18	66	M	Skin	Malignant melanoma with necrosis of right plantar (degeneration)	-	T3bN0M0	IIB	Malignant	++,60%,cytoplasm	+,60%,Cytoplasmic nucleus
B9	19	69	M	Skin	Malignant melanoma of plantar	-	T2bN0M0	IIA	Malignant	+,15%,cytoplasm	++,90%,Cytoplasmic nucleus
B10	20	51	M	Skin	Malignant melanoma of back	-	T4aN0M0	IIA	Malignant	-	++,80%,Cytoplasmic nucleus
C1	21	80	M	Skin	Malignant melanoma of right plantar	-	T4aN0M0	IIB	Malignant	-	+++,80%,Cytoplasmic nucleus
C2	22	51	M	Skin	Malignant melanoma of left upper arm with degeneration	-	T3bN0M0	IIB	Malignant	++,80%,cytoplasm	+++,80%,Cytoplasmic nucleus
C3	23	52	M	Skin	Malignant melanoma of abdomen	-	T4bN0M0	IIC	Malignant	++,50%,cytoplasm	++,50%,Cytoplasmic nucleus
C4	24	61	F	Skin	Malignant melanoma of right plantar	-	T4bN0M0	IIC	Malignant	+,15%,cytoplasm	+++,90%,Cytoplasmic nucleus
C5	25	25	M	Skin	Malignant melanoma of right plantar	-	T4bN0M0	IIC	Malignant	-	++,80%,Cytoplasmic nucleus
C6	26	41	M	Skin	Malignant melanoma of left leg	-	T4aN0M0	II	Malignant	+,30%,cytoplasm	++,90%,Cytoplasmic nucleus
C7	27	55	M	Skin	Malignant melanoma of right upper arm	-	T4N0M0	II	Malignant	-	-
C8	28	37	M	Skin	Malignant melanoma with sparse necrosis of right upper arm	-	T4aN0M0	IIB	Malignant	++,80%,cytoplasm	-
C9	29	71	M	Skin	Malignant melanoma of right groin	-	T4aN0M0	II	Malignant	-	+,15%,Cytoplasmic nucleus
C10	30	49	M	Skin	Malignant melanoma of left arm	-	T4bN1M0	IIIB	Malignant	+,60%,cytoplasm	++,80%,Cytoplasmic nucleus
D1	31	61	M	Skin	Malignant melanoma of right grion	-	T4N2M0	III	Malignant	+,20%,cytoplasm	++,80%,Cytoplasmic nucleus
D2	32	59	F	Skin	Malignant melanoma	-	T1aN0M0	I	Malignant	-	-
D3	33	61	M	Skin	Malignant melanoma of left armpit	-	T4bN0M1	IV	Malignant	-	-
D4	34	42	F	Skin	Malignant melanoma of left thumb	-	T4bN0M0	IIC	Malignant	-	+,60%,Cytoplasmic nucleus
D5	35	58	F	Skin	Malignant melanoma of left rump	-	T4aN0M0		Malignant	-	-
D6	36	71	M	Skin	Malignant melanoma of right rump	-	T4aN0M0	IIB	Malignant	-	-
D7	37	42	F	Skin	Malignant melanoma of right thigh	-	T4N0M0	II	Malignant	++,80%,cytoplasm	+++,90%,Cytoplasmic nucleus
D8	38	50	M	Skin	Malignant melanoma of left shoulder	-	T4N0M0	II	Malignant	-	-
D9	39	7	M	Skin	Malignant melanoma of sacral tail	-	T4aN0M0	IIB	Malignant	-	-
D10	40	72	F	Skin	Malignant melanoma of right waist	-	*	*	Malignant	-	-
E1	41	40	M	Skin	Malignant melanoma of right chest wall	-	T4N0M0	II	Malignant	+,60%,cytoplasm	+++,90%,Cytoplasmic nucleus
E2	42	67	F	Skin	Malignant melanoma of armpit	-	T2aN0M0	II	Malignant	++,70%,cytoplasm	++,70%,Cytoplasmic nucleus
E3	43	46	F	Skin	Malignant melanoma of right chest wall	-	T4N0M0	II	Malignant	+++,90%,cytoplasm	+++,90%,Cytoplasmic nucleus
E4	44	43	F	Skin	Malignant melanoma of right abdominal wall	-	T4aN0M0	IIB	Malignant	+,30%,cytoplasm	+,80%,Cytoplasmic nucleus
E5	45	66	M	Rectum	Malignant melanoma	-	T4bN0M0	IIC	Malignant	+++,80%,cytoplasm	+++,80%,Cytoplasmic nucleus
E6	46	84	F	Rectum	Malignant melanoma of perianal	-	T4bN0M0	II	Malignant	+,15%,cytoplasm	++,90%,Cytoplasmic nucleus
E7	47	54	F	Rectum	Malignant melanoma with sparse necrosis of anal canal	-	T4bN3M0	III	Malignant	++,80%,cytoplasm	++,80%,Cytoplasmic nucleus
E8	48	52	F	Rectum	Malignant melanoma of anal canal	-	T4N0M0	IIB	Malignant	-	++,80%,Cytoplasmic nucleus
E9	49	42	F	Rectum	Malignant melanoma of anal canal	-	T4aN0M0	IIB	Malignant	-	++,90%,Cytoplasmic nucleus
E10	50	75	M	Rectum	Malignant melanoma of perianal	-	T4aN3M0	III	Malignant	-	+,10%,Cytoplasmic nucleus
F1	51	66	F	Rectum	Malignant melanoma	-	*	*	Malignant	++,90%,cytoplasm	++,90%,Cytoplasmic nucleus
F2	52	64	M	Rectum	Malignant melanoma	-	*	*	Malignant	++,90%,cytoplasm	++,90%,Cytoplasmic nucleus
F3	53	44	F	Rectum	Malignant melanoma	-	*	*	Malignant	-	-
F4	54	64	F	Rectum	Malignant melanoma	-	T4aN0M0		Malignant	+,40%,cytoplasm	-
F5	55	67	F	Rectum	Malignant melanoma of anal canal	-	T4bN0M0	IIC	Malignant	++,90%,cytoplasm	-
F6	56	78	M	Nose	Malignant melanoma of left nasal cavity (sparse)	-	T4N0M0	IIB	Malignant	-	-
F7	57	50	M	Nose	Malignant melanoma	-	T4bN0M0	IIC	Malignant	-	-
F8	58	38	F	Nose	Malignant melanoma	-	T4N0M0	I	Malignant	-	+++,80%,Cytoplasmic nucleus
F9	59	63	M	Nose	Malignant melanoma	-	T4aN0M0	IIB	Malignant	+,60%,cytoplasm	-
F10	60	63	M	Nose	Malignant melanoma (bleeding)	-	*	*	Malignant	-	-
G1	61	47	F	Nose	Malignant melanoma with sparse necrosis	-	T2N1M0	III	Malignant	-	-
G2	62	41	F	Eye	Malignant melanoma of left eye	-	T4aN0M0	IIB	Malignant	+,20%,cytoplasm	-
G3	63	37	M	Eye	Malignant melanoma	-	T3N1M0	III	Malignant	+,60%,cytoplasm	+,60%,Cytoplasmic nucleus
G4	64	44	F	Vulva	Malignant melanoma	-	T4aN0M0	IIB	Malignant	+,30%,cytoplasm	++,70%,Cytoplasmic nucleus
G5	65	57	F	Vulva	Malignant melanoma	-	T4N0M0	III	Malignant	++,80%,cytoplasm	+++,90%,Cytoplasmic nucleus
G6	66	50	M	Esophagus	Malignant melanoma	-	*	*	Malignant	+,40%,cytoplasm	+,40%,Cytoplasmic nucleus
G7	67	64	M	Esophagus	Malignant melanoma	-	*	*	Malignant	-	++,70%,Cytoplasmic nucleus
G8	68	55	M	Stomach	Malignant melanoma	-	*	*	Malignant	++,80%,cytoplasm	+++,90%,Cytoplasmic nucleus
G9	69	73	M	Small intestine	Malignant melanoma	-	T4aN0M0	II	Malignant	++,90%,cytoplasm	+++,90%,Cytoplasmic nucleus
G10	70	70	F	Oral cavity	Malignant melanoma of left parotid gland	-			Malignant	-	+,20%,Cytoplasmic nucleus
H1	71	62	F	Urethra	Malignant melanoma	-	T4N0M0	II	Malignant	+,25%,cytoplasm	-
H2	72	51	M	Mediastinum	Malignant melanoma with degeneration and necrosis	-	T4N0M0	II	Malignant	+,30%,cytoplasm	++,70%,Cytoplasmic nucleus
H3	73	62	M	Scrotum	Malignant melanoma	-	T4bN0M0	IIC	Malignant	-	-
H4	74	46	M	Scrotum	Malignant melanoma with degeneration	-	T4aN0M0	IIB	Malignant	-	-
H5	75	65	M	Lymph node	Metastatic malignant melanoma of right groin	-	*	*	Metastasis	+,30%，cytoplasm	++,60%,Cytoplasmic nucleus
H6	76	43	F	Lymph node	Metastatic malignant melanoma of armpit	-	*	*	Metastasis	-	+++,95%,Cytoplasmic nucleus
H7	77	76	M	Lymph node	Metastatic malignant melanoma	-	*	*	Metastasis	++,80%，cytoplasm	++,80%,Cytoplasmic nucleus
H8	78	38	M	Lymph node	Metastatic malignant melanoma with sparse necrosis of armpit	-	*	*	Metastasis	+,50%，cytoplasm	+,40%,Cytoplasmic nucleus
H9	79	51	M	Lymph node	Metastatic malignant melanoma of left armpit	-	*	*	Metastasis	+++,90%，cytoplasm	++,80%,Cytoplasmic nucleus
H10	80	61	M	Lymph node	Metastatic malignant melanoma of right groin	-	*	*	Metastasis	++,70%，cytoplasm	+,50%,Cytoplasmic nucleus
I1	81	49	M	Lymph node	Metastatic malignant melanoma of right groin (degeneration)	-	*	*	Metastasis	+,50%，cytoplasm	++,50%,Cytoplasmic nucleus
I2	82	55	M	Lymph node	Metastatic malignant melanoma with sparse necrosis of left armpit	-	*	*	Metastasis	++,60%，cytoplasm	+,30%,Cytoplasmic nucleus
I3	83	65	M	Lymph node	Metastatic malignant melanoma of groin	-	*	*	Metastasis	+,20%，cytoplasm	++,60%,Cytoplasmic nucleus
I4	84	38	M	Lymph node	Metastatic malignant melanoma with sparse necrosis of left armpit	-	*	*	Metastasis	+,30%，cytoplasm	++,70%,Cytoplasmic nucleus
I5	85	65	M	Lymph node	Metastatic malignant melanoma of groin	-	*	*	Metastasis	-	+,40%,Cytoplasmic nucleus
I6	86	33	M	Lymph node	Metastatic malignant melanoma of left groin	-	*	*	Metastasis	+,10%，cytoplasm	++,90%,Cytoplasmic nucleus
I7	87	62	M	Lymph node	Metastatic malignant melanoma of left groin	-	*	*	Metastasis	-	-
I8	88	64	M	Lymph node	Metastatic malignant melanoma	-	*	*	Metastasis	+,40%，cytoplasm	-
I9	89	-	-	-	-	-	*	*	-	*
I10	90	-	-	-	-	-	*	*	-	*
J1	91	38	M	Skin	Skin nevus of temporal part	-	*	*	Benign	-	+,40%,Cytoplasmic nucleus
J2	92	30	F	Skin	Compound nevus of right face	-	*	*	Benign	-	++,90%,Cytoplasmic nucleus
J3	93	10	F	Skin	Intradermal nevus of right arm	-	*	*	Benign	-	++,90%,Cytoplasmic nucleus
J4	94	0.5	M	Skin	Compound nevus of right foot back	-	*	*	Benign	-	++,80%,Cytoplasmic nucleus
J5	95	29	F	Skin	Intradermal nevus of face	-	*	*	Benign	-	++,80%,Cytoplasmic nucleus
J6	96	2	F	Skin	Compound nevus of left shoulder	-	*	*	Benign	-	++,90%,Cytoplasmic nucleus
J7	97	25	M	Skin	Junction nevus of forehead	-	*	*	Benign	-	++,90%,Cytoplasmic nucleus
J8	98	11	M	Skin	Compound nevus of left leg (sparse)	-	*	*	Benign	-	+,10%,Cytoplasmic nucleus

Find overlapping cases with this tissue array:

For all inquiries regarding product specifications, please contact us at support@arraysbank.com

	1	2	3	4	5	6	7	8	9	10
A	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
B	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
C	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
D	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
E	Ski	Ski	Ski	Ski	Rec	Rec	Rec	Rec	Rec	Rec
F	Rec	Rec	Rec	Rec	Rec	Nos	Nos	Nos	Nos	Nos
G	Nos	Eye	Eye	Vul	Vul	Eso	Eso	Sto	Sma	Ora
H	Ure	Med	Scr	Scr	Lym	Lym	Lym	Lym	Lym	Lym
I	Lym	Lym	Lym	Lym	Lym	Lym	Lym	Lym	-	-
J	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski

	1	2	3	4	5	6	7	8	9	10
A	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
B	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
C	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
D	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
E	Ski	Ski	Ski	Ski	Rec	Rec	Rec	Rec	Rec	Rec
F	Rec	Rec	Rec	Rec	Rec	Nos	Nos	Nos	Nos	Nos
G	Nos	Eye	Eye	Vul	Vul	Eso	Eso	Sto	Sma	Ora
H	Ure	Med	Scr	Scr	Lym	Lym	Lym	Lym	Lym	Lym
I	Lym	Lym	Lym	Lym	Lym	Lym	Lym	Lym	-	-
J	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski

	1	2	3	4	5	6	7	8	9	10
A	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
B	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
C	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
D	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski
E	Ski	Ski	Ski	Ski	Rec	Rec	Rec	Rec	Rec	Rec
F	Rec	Rec	Rec	Rec	Rec	Nos	Nos	Nos	Nos	Nos
G	Nos	Eye	Eye	Vul	Vul	Eso	Eso	Sto	Sma	Ora
H	Ure	Med	Scr	Scr	Lym	Lym	Lym	Lym	Lym	Lym
I	Lym	Lym	Lym	Lym	Lym	Lym	Lym	Lym	-	-
J	Ski	Ski	Ski	Ski	Ski	Ski	Ski	Ski